TAMBAYA 1

CAT # Sunan samfur Bayani
Saukewa: CPD100608 ASK1-Inhibitor-10 ASK1 Inhibitor 10 shine mai hanawa na baka mai hanawa na siginar apoptosis mai daidaita kinase 1 (ASK1). Yana da zaɓi don ASK1 akan ASK2 haka kuma MEKK1, TAK-1, IKKβ, ERK1, JNK1, p38α, GSK3β, PKCθ, da B-RAF. Yana hana haɓakar streptozotocin a cikin JNK da p38 phosphorylation a cikin ƙwayoyin β na pancreatic na INS-1 a cikin hanyar dogaro da hankali.
Saukewa: CPD100607 K811 K811 shine takamaiman mai hanawa ASK1 wanda ke tsawaita rayuwa a cikin ƙirar linzamin kwamfuta na amyotrophic lateral sclerosis. K811 da kyau ya hana yaduwar kwayar halitta a cikin layin salula tare da babban maganganun ASK1 kuma a cikin HER2-overexpressing GC Kwayoyin. Jiyya tare da K811 ya rage girman ciwace-ciwacen ciwace-ciwacen daji ta hanyar raguwar alamomin yaduwa.
Saukewa: CPD100606 K812 K812 shine takamaiman mai hanawa ASK1 wanda aka gano don tsawaita rayuwa a cikin ƙirar linzamin kwamfuta na amyotrophic lateral sclerosis.
Saukewa: CPD100605 Saukewa: MSC-2032964A MSC 2032964A mai ƙarfi ne kuma mai hanawa ASK1 (IC50 = 93 nM). Yana toshe LPS-induced ASK1 da p38 phosphorylation a cikin al'ada linzamin kwamfuta astrocytes da kuma kashe neuroinflammation a cikin wani linzamin kwamfuta model EAE. MSC 2032964A abu ne mai yiwuwa a baka kuma yana shiga kwakwalwa.
Saukewa: CPD100604 Selonsertib Selonsertib, wanda kuma aka sani da GS-4997, shine mai hanawa na baka mai hanawa na siginar apoptosis mai sarrafa kinase 1 (ASK1), tare da yuwuwar rigakafin kumburi, antineoplastic da ayyukan anti-fibrotic. GS-4997 yana hari kuma yana ɗaure zuwa yankin kinase na catalytic na ASK1 a cikin hanyar gasa ta ATP, ta haka yana hana phosphorylation da kunnawa. GS-4997 yana hana samar da cytokines mai kumburi, saukar da tsarin bayyana kwayoyin halittar da ke cikin fibrosis, yana hana apoptosis mai yawa kuma yana hana yaduwar salula.
da

Tuntube Mu

Tambaya

Sabbin Labarai

  • Manyan Abubuwa 7 A cikin Binciken Magunguna A cikin 2018

    Manyan Abubuwa 7 A Cikin Binciken Magunguna Na...

    Kasancewar kasancewa ƙarƙashin matsin lamba don yin gasa a cikin yanayi mai ƙalubale na tattalin arziki da fasaha, dole ne kamfanonin harhada magunguna da fasahar kere-kere su ci gaba da haɓaka cikin shirye-shiryensu na R&D don ci gaba ...

  • ARS-1620: Sabuwar mai hanawa don KRAS-mutant cancers

    ARS-1620: Sabuwar mai hanawa don K ...

    A cewar wani binciken da aka buga a cikin Cell, masu bincike sun kirkiro wani takamaiman mai hanawa don KRASG12C mai suna ARS-1602 wanda ya haifar da koma baya a cikin mice. "Wannan binciken yana ba da shaida a cikin vivo shaida cewa mutant KRAS na iya zama ...

  • AstraZeneca yana karɓar haɓakar tsari don magungunan oncology

    AstraZeneca yana karɓar haɓaka tsari don ...

    AstraZeneca ta sami haɓaka ninki biyu don fayil ɗin cutar sankara a ranar Talata, bayan hukumomin Amurka da na Turai sun karɓi ƙa'idodin ƙa'idodin magungunanta, matakin farko na samun amincewar waɗannan magunguna. ...

WhatsApp Online Chat!